Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada

Numerous RX and OTC drug products and supplements from a wide range of therapeutic categories may use DBP or DEP as excipients in oral dosage forms. The potential effects of human exposure to these phthalates through medications are unknown and warrant further investigation.